Your browser doesn't support javascript.
loading
Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort.
Matta, Komodo; Viallon, Vivian; Botteri, Edoardo; Peveri, Giulia; Dahm, Christina; Nannsen, Anne Østergaard; Olsen, Anja; Tjønneland, Anne; Elbaz, Alexis; Artaud, Fanny; Marques, Chloé; Kaaks, Rudolf; Katzke, Verena; Schulze, Matthias B; Llanaj, Erand; Masala, Giovanna; Pala, Valeria; Panico, Salvatore; Tumino, Rosario; Ricceri, Fulvio; Derksen, Jeroen W G; Nøst, Therese Haugdahl; Sandanger, Torkjel M; Borch, Kristin Benjaminsen; Quirós, J Ramón; Castro-Espin, Carlota; Sánchez, Maria-José; Atxega, Amaia Aizpurua; Cirera, Lluís; Guevara, Marcela; Manjer, Jonas; Tin Tin, Sandar; Heath, Alicia; Touvier, Mathilde; Goldberg, Marcel; Weiderpass, Elisabete; Gunter, Marc J; Freisling, Heinz; Riboli, Elio; Ferrari, Pietro.
Afiliação
  • Matta K; International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Viallon V; International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Botteri E; Cancer Registry of Norway (Kreftregisteret), Oslo, Norway.
  • Peveri G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Dahm C; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Nannsen AØ; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Olsen A; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Tjønneland A; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Elbaz A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Artaud F; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Marques C; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Kaaks R; Inserm, Université Paris Saclay, Institut Gustave Roussy, Team Exposome, Heredity, Cancer and Health, CESP UMR 1018, 94807, Villejuif, France.
  • Katzke V; Inserm, Université Paris Saclay, Institut Gustave Roussy, Team Exposome, Heredity, Cancer and Health, CESP UMR 1018, 94807, Villejuif, France.
  • Schulze MB; Inserm, Université Paris Saclay, Institut Gustave Roussy, Team Exposome, Heredity, Cancer and Health, CESP UMR 1018, 94807, Villejuif, France.
  • Llanaj E; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Masala G; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Pala V; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Panico S; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
  • Tumino R; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Ricceri F; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Derksen JWG; Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
  • Nøst TH; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Sandanger TM; Dipartimento di Medicina Clinica, Federico II University, Naples, Italy.
  • Borch KB; Hyblean Association for Epidemiological Research, AIRE ONLUS, Ragusa, Italy.
  • Quirós JR; Centre for Biostatistics, Epidemiology, Department of Clinical and Biological Sciences, and Public Health (C-BEPH), University of Turin, Turin, Italy.
  • Castro-Espin C; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Sánchez MJ; K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
  • Atxega AA; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
  • Cirera L; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
  • Guevara M; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
  • Manjer J; Public Health Directorate, Asturias, Spain.
  • Tin Tin S; International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Heath A; Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Touvier M; Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Goldberg M; Escuela Andaluza de Salud Pública (EASP), 18011, Granada, Spain.
  • Weiderpass E; Instituto de Investigación Biosanitaria ibs.GRANADA, 18012, Granada, Spain.
  • Gunter MJ; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
  • Freisling H; Department of Preventive Medicine and Public Health, University of Granada, 18071, Granada, Spain.
  • Riboli E; Sub Directorate for Public Health and Addictions of Gipuzkoa, Ministry of Health of the Basque Government, San Sebastian, Spain.
  • Ferrari P; Epidemiology of Chronic and Communicable Diseases Group, Biodonostia Health Research Institute, San Sebastián, Spain.
BMC Med ; 22(1): 210, 2024 May 29.
Article em En | MEDLINE | ID: mdl-38807179
ABSTRACT

BACKGROUND:

Healthy lifestyles are inversely associated with the risk of noncommunicable diseases, which are leading causes of death. However, few studies have used longitudinal data to assess the impact of changing lifestyle behaviours on all-cause and cancer mortality.

METHODS:

Within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, lifestyle profiles of 308,497 cancer-free adults (71% female) aged 35-70 years at recruitment across nine countries were assessed with baseline and follow-up questionnaires administered on average of 7 years apart. A healthy lifestyle index (HLI), assessed at two time points, combined information on smoking status, alcohol intake, body mass index, and physical activity, and ranged from 0 to 16 units. A change score was calculated as the difference between HLI at baseline and follow-up. Associations between HLI change and all-cause and cancer mortality were modelled with Cox regression, and the impact of changing HLI on accelerating mortality rate was estimated by rate advancement periods (RAP, in years).

RESULTS:

After the follow-up questionnaire, participants were followed for an average of 9.9 years, with 21,696 deaths (8407 cancer deaths) documented. Compared to participants whose HLIs remained stable (within one unit), improving HLI by more than one unit was inversely associated with all-cause and cancer mortality (hazard ratio [HR] 0.84; 95% confidence interval [CI] 0.81, 0.88; and HR 0.87; 95% CI 0.82, 0.92; respectively), while worsening HLI by more than one unit was associated with an increase in mortality (all-cause mortality HR 1.26; 95% CI 1.20, 1.33; cancer mortality HR 1.19; 95% CI 1.09, 1.29). Participants who worsened HLI by more than one advanced their risk of death by 1.62 (1.44, 1.96) years, while participants who improved HLI by the same amount delayed their risk of death by 1.19 (0.65, 2.32) years, compared to those with stable HLI.

CONCLUSIONS:

Making healthier lifestyle changes during adulthood was inversely associated with all-cause and cancer mortality and delayed risk of death. Conversely, making unhealthier lifestyle changes was positively associated with mortality and an accelerated risk of death.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilo de Vida Saudável / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilo de Vida Saudável / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article